regencellbioscience.com (RGC): Net earnings per share growth forecast for next year
The development of neuropreparations based on Chinese medicine by Regencell Bioscience (RGC) is in the early stages of testing without clear market advantages. The project relies on a narrow staff of specialized scientists motivated by scientific freedom. The consensus on next year's earnings per share reflects a trend in expectations where the level of 0.00 is the current value. Consequently, Regencell Bioscience (RGC) is implementing ESG and bioethics principles into its raw material sourcing.
Comprehensive metric breakdowns and analytics for regencellbioscience.com (RGC)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- debt and solvency information:
Total Debt to Capital Regencell Bioscience|RGC - Long-Term Debt to Equity|Short-Term Debt to Capital Regencell Bioscience Holdings Limited|RGC - Company Total Debt Obligations|Debt to Book Capitalization Ratio Regencell Bioscience|RGC - Long-Term Debt|Company Short-Term Debt Regencell Bioscience|Quick Ratio regencellbioscience.com
- net income and valuation ratios data:
RGC - Net Income|Projected Future Earnings Regencell Bioscience|RGC - Business Payback Period|Forward P/E Multiple Regencell Bioscience|RGC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Regencell Bioscience|RGC - Operating profit before amortization|Net earnings per share (EPS TTM) Regencell Bioscience|RGC - Net earnings per share for the last 12 months|Quarterly EPS earnings growth regencellbioscience.com|RGC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Regencell Bioscience
Initial company analysis:RGC, Regencell
This indicator measures the percentage change in expected earnings per share for the coming year, reflecting the speed at which institutional players adjust market valuations. By analyzing the one-year forward EPS growth rate, an investor can discern speculative expectations, which for Regencell Bioscience (RGC) remain purely hypothetical due to a lack of revenue and pricing power during the clinical trial stage.
Competitors of Regencell Bioscience
BIIB (Biogen Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Neurocrine Corp NBIX|Net earnings per share growth forecast for next year Axsome Therapeutics (AXSM)|Net earnings per share growth forecast for next year ACAD (acadia-pharm.com)|Net earnings per share growth forecast for next year Xenon XENE|Viking Therapeutics Inc - Net earnings per share growth forecast for next year|SUPN: Expected earnings per share growth for next year|Expected earnings per share trend next year CPRX (Catalyst Corp)|DNLI: Earnings growth forecast for next year|HRMY (harmonybiosciences.com) - Net earnings per share growth forecast for next year|BHVN (Biohaven) - Earnings growth forecast for next year|Amylyx Pharmaceuticals Inc (AMLX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Trevi Pharma (TRVI)|PRAX - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Anavex Life Sciences AVXL|Consensus forecast of earnings per share growth for next year ceribell.com (CBLL)|Prothena - Earnings growth forecast for next year|Alector, Inc. (ALEC) - Expected earnings per share growth for next year|ANNX: Earnings growth forecast for next year|OMER - Consensus forecast of earnings per share growth for next year|NGNE (Neurogene Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year acimmune.com ACIU|Net earnings per share growth forecast for next year Voyager Therapeutics, Inc. (VYGR)|Neumora - Projected earnings per share growth rate for next year|Earnings growth forecast for next year SCLX (Scilex Holding Co.)|TVGN - Expected earnings per share growth for next year|Alpha Cognition Corp - Earnings growth forecast for next year|Expected net earnings per share growth next year Cognition Therapeutics Inc.|Inhibikase Therapeutics, Inc. (IKT) - Net earnings per share growth forecast for next year|Cassava Sciences Inc - Expected earnings per share trend next year|ASRT (Assertio Holdings) - Earnings growth forecast for next year|COYA - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year VTGN|Expected earnings per share growth for next year ovidrx.com OVID|Net earnings per share growth forecast for next year Acumen Pharmaceuticals, Inc. ABOS|CRVO: Projected earnings per share growth rate for next year|Alterity Therapeutics Ltd - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc.|PEPG (pepgen.com) - Expected earnings per share growth for next year|Jupiter Neurosciences, Inc. (JUNS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Relmada Therapeutics, Inc.|ANVS: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Grace Therapeutics, Inc. (GRCE)|AIFF - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|Expected earnings per share trend next year NRSN|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year MetaVia Inc|NRXS: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Helius Medical Technologies HSDT|PASG (Passage Bio Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Neuphoria NEUP|Net earnings per share growth forecast for next year Minerva Neurosciences, Inc. (NERV)|Athira Pharma Inc - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ADXN (Addex Therapeutics, Ltd.)|ALZN - Expected earnings per share growth for next year|Cyclerion - Earnings growth forecast for next year|Expected net earnings per share growth next year Protagenic Therapeutics|pasitheaclinics.com (KTTA) - Net earnings per share growth forecast for next year|CRGT (Cortigent) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Avenue Therapeutics, Inc|Net earnings per share growth forecast for next year BCLI|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|CHRO (chromocell.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ELYM (Eliem Therapeutics Inc.)|Intra-Cellular Therapies Inc. - Net earnings per share growth forecast for next year|Longboard Pharma - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharma MRNS|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year neurobopharma.com (NRBO)|Net earnings per share growth forecast for next year Sage Therapeutics|Synaptogenix Inc. (SNPX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year TRVN|Expected earnings per share growth for next year vigilneuro.com VIGL|Earnings growth forecast for next year WENA (Anew Medical)|Consensus forecast of earnings per share growth for next year cerevel.com (CERE)
